Roni Haas

Response to GLP-1 Weight Loss Drugs Varies Across Ancestry Groups A large-scale biobank study has uncovered a genetic link between variants of the PTPRU gene and response to GLP-1 drugs @HaasRoni @UCLAHealth #GLP1 #biobanks #geneticvariants hubs.li/Q048SDZc0

Big news! 🚨 Our new paper on the UCLA Biobank is officially out now in Cell! Excited to share what we’ve been working on 🧬✨!

Advancing precision health discovery in a genetically diverse health system @CellCellPress @GeschwindLab @HaasRoni cell.com/cell/fulltext/…

#PCFRetreat25 @PCF_Science Antibody-Dynamite Conjugate Table#2 @HaasRoni @petegodolphin @GalinaSemenova_ @RamyarMolania @DrGallent

The proteogenomics of #ProstateCancer radioresistance. @HaasRoni @UCLA joins @AndreaMiyahira @PCFnews to discuss research on prostate cancer radioresistance, focusing on differences between conventional and hypofractionated radiation therapy approaches. #FullVideo on UroToday > bit.ly/4aAQYCq

The proteogenomics of #ProstateCancer radioresistance. @HaasRoni @UCLA joins @AndreaMiyahira @PCFnews to discuss research on prostate cancer radioresistance, focusing on differences between conventional and hypofractionated radiation therapy approaches. #FullVideo on UroToday > bit.ly/4aAQYCq

#PCFRetreat24 LIKE 👇to help us win a prize! Love making new friends @PCF_Science @DanielBRosen @AmandaCLeiter @HaasRoni

The Proteogenomics of Prostate Cancer Radioresistance out on @CRC_AACR aacrjournals.org/cancerrescommu… #ProstateCancer radioresistance☢️ remains a challenge in radiotherapy, with aggressive relapses often occurring, but the underlying molecular mechanisms are not well understood. This study analyzed the genomic🧬 transcriptomic, and proteomic profiles of prostate cancer cells exposed to both conventional and hypofractionated radiotherapy, revealing that radioresistance is associated with genomic instability and impaired DNA mismatch repair, regardless of the treatment regimen. Key cancer driver genes exhibited distinct RNA and protein-level changes, with conventional fractionation triggering a more aggressive biomolecular response than hypofractionation. The study identified POLQ (DNA Polymerase Theta) as a promising radiosensitizer, demonstrating its ability to modulate radioresistance and predict treatment outcomes in patient cohorts, providing new insights into the lethal nature of prostate cancer. @HaasRoni @bethneilsen @Chenghao_Zhu @DrAndrewLoblaw @dr_vesi @AmarUKishan @DrMLChua @KislingerThomas @DrStanLiu

Fun at the #PCFRetreat2023! @PCFnews

The PCF Young Investigator Awards offer career and project support for young proven investigators in postdoctoral fellowships or who have recently achieved junior faculty positions. Congratulations to all our 2022 Award Winners! 🔬 🏆 bit.ly/3W3PrwY

I am very excited to receive the 2022 Todd Boehly-PCF Young Investigator Award from the Prostate Cancer Foundation! Thank you PCF for believing in me and for the incredible support you are giving to help develop young investigator careers. @PCFnews @PCF_Science @TheBoutrosLab

Our paper is finally out. Great work by Dean and @HaasRoni . RESIC: A Tool for Comprehensive Adenosine to Inosine RNA Editing Site Identification and Classification frontiersin.org/article/10.338…

Looking for RNA-seq raw data from COVID patients. Anyone willing to share/collaborate? We like to test our gene/pathway expression statistical tool and maybe find something useful. Pls RT.

Congratulation Roni @HaasRoni winning third prize for best talk at #RNA_Sperling2019 meeting. Stay tuned for our BiSEK tool.

Got back from #EditingGRC Great science, good friends and lots of wine with @HaasRoni

Congratulations Roni Haas on winning the best poster prize at the 2018 RNA biology meeting in memory of Prof. Yossi Sperling.

Our new paper is out @HaasRoni #mdpigenes A-to-I RNA Editing Affects lncRNAs Expression after Heat Shock mdpi.com/2073-4425/9/12… @Genes_MDPI

Our new preprint @HaasRoni

A-to-I RNA Editing Affects lncRNAs Expression after Heat Shock preprints.org/manuscript/201… @Preprints_org